Drs. Mazepa and Cataland formed the United States Thrombotic Microangiopathy (USTMA) Consortium in 2014 as a grassroots effort to organize research efforts in the thrombotic microangiopathies.
The USTMA now incorporates 15 large US referral centers with:
a large referral base of patients with TMAs
a minimum of 1 site leader with a career interest in clinical/translational research in TMA and
adequate clinical/translational research facilities and resources to participate in these research activities.
There exists a strong sense of collaboration and cohesiveness among the group.